Nicole Murphy insider trades
Open-market stock purchases and sales by Nicole Murphy, Head of Pharm Ops and Tech at Biogen Inc, from SEC Form 4 filings since Feb 10, 2022.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +15%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 13, 2026 | BIIB Biogen Inc | Bought (not open market) | — |
| Feb 12, 2026 | BIIB Biogen Inc | Bought | $585 |
| Feb 6, 2026 | BIIB Biogen Inc | Bought (not open market) | — |
| Feb 6, 2026 | BIIB Biogen Inc | Sold (not open market) | $205K |
| Feb 6, 2026 | BIIB Biogen Inc | Sold (not open market) | $184K |
| Feb 6, 2026 | BIIB Biogen Inc | Sold (not open market) | $283K |
| Feb 6, 2026 | BIIB Biogen Inc | Bought (not open market) | — |
| Feb 6, 2026 | BIIB Biogen Inc | Bought (not open market) | — |
Companies traded
- BIIB Biogen Inc: 1 buy, last Feb 13, 2026